COUR Pharmaceuticals is a startup based in the United States.
Based in the United States, COUR Pharmaceuticals is a startup.
COUR Pharmaceuticals develops nanoparticle therapies that deliver disease-specific antigens or allergens to antigen-presenting cells in the spleen and liver through natural, non-inflammatory phagocytic pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.